Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.

Journal of cellular and molecular medicine - 1 Jan 2021

Huo Junyu, Wu Liqun, Zang Yunjin

Abstract excerpt

Hepatocellular carcinoma (HCC) is a heterogeneous malignancy closely related to metabolic reprogramming. We investigated how CTNNB1 mutation regulates the HCC metabolic phenotype and thus affects the prognosis of HCC. We obtained the mRNA expression profiles and clinicopathological data from The Cancer Genome Atlas (TCGA), the International Cancer Genomics Consortium (ICGC) and the Gene Expression Omnibus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Carcinoma, Hepatocellular
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Ontology

Share to Liver Neoplasms

Share to Reproducibility of Results

Share to Survival Analysis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 33300278
DOI: 10.1111/jcmm.16181
PMCID: PMC7812275

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of a CTNNB1-associated metabolic prognostic model for hepatocellular carcinoma.PMID 33300278Read ↗

Construction and Validation of a Metabolic Reprogramming Related Prognostic Model for Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and Validation of a Novel Metabolism‑Related Prognostic Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinomaSemantic proximity Read ↗

Identification of a novel metabolism‑related prognostic signature in hepatocellular carcinoma through bioinformatics analysis and validation through experimental studiesSemantic proximity Read ↗

Prognostic Exploration of Metabolism-Related Genes in Hepatocellular Carcinoma and Pan-CancerSemantic proximity Read ↗

Metabolism‐associated molecular classification of hepatocellular carcinomaSemantic proximity Read ↗

Prognostic Significance and Immunometabolism Landscapes Analysis of a Novel Lipid Metabolism-Related Gene Signature in Extrahepatic Metastasis of Hepatocellular Carcinoma.Semantic proximity Read ↗

A Novel Immune-Metabolic Prognostic Model Stratifies Survival and Personalizes Therapy in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCCSemantic proximity Read ↗

Identification of a four‐gene metabolic signature predicting overall survival for hepatocellular carcinomaSemantic proximity Read ↗

METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discoverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.